Additionally, a study in renal carcinoma demonstrated that genistein suppresses tumor cell proliferation by enhancing CDKN2A expression through promoter hypomethylation [37], suggesting an epigenetic mechanism that may underlie CDKN2A activation in certain cancers. Here, CDKN2A is linked to neoplasm.